Extract from the Register of European Patents

EP About this file: EP0068240

EP0068240 - 2-Acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.07.1986
Database last updated on 09.04.2026
Most recent event   Tooltip21.07.1986No opposition filed within time limitpublished on 10.09.1986 [1986/37]
Applicant(s)For all designated states
Kali-Chemie Pharma GmbH
Hans-Böckler-Allee 20
D-30173 Hannover / DE
[1983/01]
Inventor(s)01 / Zeugner, Horst, Dipl.-Chem. Dr.rer.nat.
Havelweg 10
D-3000 Hannover 73 / DE
02 / Römer, Dietmar, Dr.
Lettenweg 111
CH-4123 Allschwil / CH
03 / Benson, Werner, Dipl.-Chem. Dr.rer.nat.
In der Steinbreite 39
D-3000 Hannover 91 / DE
04 / Liepmann, Hans, Dipl.-Chem.Dr.rer.nat.
Auf dem Emmerberg 17
D-3000 Hannover 1 / DE
05 / Milkowski, Wolfgang, Dipl.-Chem.Dr.rer.nat.
Fasanenweg 13
D-3167 Burgdorf / DE
[1983/01]
Representative(s)Lauer, Dieter
c/o Kali-Chemie Aktiengesellschaft
Hans-Böckler-Allee 20
30173 Hannover / DE
[N/P]
Former [1983/01]Lauer, Dieter, Dr.
c/o Kali-Chemie Aktiengesellschaft Hans-Böckler-Allee 20
D-30173 Hannover / DE
Application number, filing date82105139.812.06.1982
[1983/01]
Priority number, dateDE1981312401319.06.1981         Original published format: DE 3124013
[1983/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0068240
Date:05.01.1983
Language:DE
[1983/01]
Type: B1 Patent specification 
No.:EP0068240
Date:25.09.1985
Language:DE
[1985/39]
Search report(s)(Supplementary) European search report - dispatched on:EP06.10.1982
ClassificationIPC:C07D405/14, C07D409/14, C07D409/04, C07D405/04, C07D401/04, C07D403/04, A61K31/55
[1983/01]
CPC:
C07D401/04 (EP,US); A61P25/04 (EP); C07D213/50 (EP,US);
C07D267/14 (EP,US); C07D401/12 (EP,US); C07D401/14 (EP,US);
C07D403/04 (EP,US); C07D405/04 (EP,US); C07D405/14 (EP,US);
C07D409/04 (EP,US); C07D409/14 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1983/01]
TitleGerman:2-Acylaminomethyl-1,4-benzodiazepin-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel[1983/01]
English:2-Acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them[1983/01]
French:Acylaminométhyl-2-benzodiazépines-1,4, leur préparation et produits intermédiaires et produit pharmaceutiques qui les contiennent[1985/39]
Former [1983/01]Acylaminométhyl-2-benzoxodiazépines-1,4, leur préparation et produits intermédiaires et produit pharmaceutiques qui les contiennent
Examination procedure22.06.1983Examination requested  [1983/35]
03.08.1984Despatch of a communication from the examining division (Time limit: M04)
11.10.1984Reply to a communication from the examining division
29.11.1984Despatch of communication of intention to grant (Approval: )
20.12.1984Communication of intention to grant the patent
16.02.1985Fee for grant paid
16.02.1985Fee for publishing/printing paid
Opposition(s)26.06.1986No opposition filed within time limit [1986/37]
Fees paidRenewal fee
25.06.1984Renewal fee patent year 03
22.06.1985Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.